GAMMA Investing LLC Buys 315 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

GAMMA Investing LLC grew its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 32.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,300 shares of the biotechnology company’s stock after buying an additional 315 shares during the period. GAMMA Investing LLC’s holdings in Axon Enterprise were worth $773,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Quent Capital LLC grew its position in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the period. Versant Capital Management Inc lifted its position in shares of Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after acquiring an additional 95 shares during the period. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $41,000. Finally, Planning Capital Management Corp increased its position in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

AXON opened at $601.06 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market capitalization of $45.83 billion, a P/E ratio of 155.31, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04. The company’s 50 day simple moving average is $593.68 and its 200-day simple moving average is $440.17. Axon Enterprise, Inc. has a one year low of $241.72 and a one year high of $698.67.

Insider Buying and Selling at Axon Enterprise

In other news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the sale, the director now owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This represents a 3.67 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 51,545 shares of company stock worth $31,159,317. Insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, JMP Securities upped their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $488.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.